| US 7,585,953 B2 | ||
| Antibodies specific for TAT285-1 | ||
| Ruihuan Chen, Foster City, Calif. (US); Heidi S. Phillips, Palo Alto, Calif. (US); P. Mickey Williams, Half Moon Bay, Calif. (US); Thomas Wu, San Francisco, Calif. (US); and Zemin Zhang, Foster City, Calif. (US) | ||
| Assigned to Genentech, Inc., South San Francisco, Calif. (US) | ||
| Filed on Sep. 13, 2005, as Appl. No. 11/226,554. | ||
| Application 11/226554 is a continuation of application No. 10/177488, filed on Jun. 19, 2002, abandoned. | ||
| Claims priority of provisional application 60/366869, filed on Mar. 20, 2002. | ||
| Prior Publication US 2006/0147373 A1, Jul. 06, 2006 | ||
| Int. Cl. C07K 16/00 (2006.01); C12P 21/08 (2006.01); A61K 39/395 (2006.01); C12P 21/04 (2006.01); C07H 21/04 (2006.01) | ||
| U.S. Cl. 530—387.9 [424/130.1; 424/133.1; 424/141.1; 424/155.1; 424/179.1; 424/181.1; 424/183.1; 435/69.6; 530/387.1; 530/387.3; 530/388.1; 530/388.8; 530/391.3; 530/391.7] | 16 Claims |
| 1. An isolated antibody that binds to a polypeptide selected from:
(a) the polypeptide sequence of SEQ ID NO:145;
(b) a polypeptide encoded by the nucleotide sequence of SEQ ID NO:68; or
(c) a polypeptide encoded by the full-length coding region of the nucleotide sequence of SEQ ID NO:68.
|